[1] Editas Medicine Announces Positive Initial EDIT-301Safety And Efficacy Data From The First Four Patients Treated In The RUBY TrialAnd The First Patient Treated In The EdiTHAL Trial. Retrieved June 9, 2023 fromhttps://ir.editasmedicine.com/news-releases/news-release-details/editas-medicine-announces-positive-initial-edit-301-safety-and